Nitric oxide mediates murine cytomegalovirus-associated pneumonitis in lungs that are free of the virus

Journal of Clinical Investigation

Volumn 100, Issue 7, 1997, Pages 1822-1830

  Tanaka, Kazuo ^a   Nakazawa, Hiroe ^a   Okada, Keiko ^a   Umezawa, Kazuo ^a   Fukuyama, Naoto ^a   Koga, Yasuhiro ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

Cytokine; Cytomegalovirus; Inducible nitric oxide synthetase; Interstitial pneumonitis; Nitric oxide

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HYDROXYL RADICAL; INTERLEUKIN 2; INTERLEUKIN 6; MESSENGER RNA; MONOCLONAL ANTIBODY CD3; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CYTOMEGALOVIRUS; ENZYME INDUCTION; INTERSTITIAL PNEUMONIA; LUNG INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 0030964676     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119710     Document Type: Article

References (45)

1. Grundy, J.E., J.D. Shanley, and P.D. Griffith. 1987. Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunological condition? Lancet. 2:996-1000).
2. Zaia, J.A. 1991. Pathogenesis of CMV-associated disease in 1990. Transplant. Proc. 23:1-4.
3. Forman, S.J. Bone marrow transplantation. Transplant. Proc. 23:110-114.
4. Broaddus, C., M.D. Dake, M.S. Stulbarg, W. Blumenfeld, W.K. Handley, J.A. Golden, and P.C. Hopewell. 1985. Bronchoalveolar lavage and transbronchial biopsy for the diagnosis of pulmonary infections in the acquired immunodeficiency syndrome. Ann. Intern. Med. 102:747-752.
5. Jacobson, M.A., and J. Mills. 1988. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 108:585-594.
6. Gallant, J.E., R.D. Moore, D.D. Richman, J. Keruly, R.E. Chaisson, and the Zidovudine Epidemiology Study Group. 1992. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J. Infect. Dis. 166:1223-1227.
7. Rubin, R.H. 1994. Infection in the organ transplant recipient. In Clinical Approach to Infection in the Compromised Host (3rd. Ed). R.H. Rubin and L.S. Young, editors. Plenum Publishing Corp., New York. 629-705.
8. Bowden, R.A., and J.D. Meyers. 1994. Infectious complicating bone marrow transplantation. In Clinical Approach to Infection in the Compromised Host (3rd. Ed). R.H. Rubin and L.S. Young, editors. Plenum Publishing Corp., New York. 601-628.
9. Tanaka, K., Y. Koga, Y.-Y. Lu, X.-Y. Zhang, Y. Wang, G. Kimura, and K. Nomoto. 1994. Murine cytomegalovirus-associated pneumonitis in the lungs free of the virus. J. Clin. Invest. 94:1019-1025.
10. Hirsch, R., R.E. Gress, D.H. Pluznik, M. Eckhaus, and J.A. Bluestone. 1989. Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells. J. Immunol. 142:737-743.
11. Lukacs, N.W., and P.A. Ward. 1996. Inflammatory mediators, cytokines, and adhesion molecules in pulmonary inflammation and injury. Adv. Immunol. 62:257-304.
12. Schmidt, H.H.H.W., and U. Water. 1994. NO at work. Cell. 78:919-925.
13. Igarashi, R., J. Hoshino, M. Takenaga, S. Kawai, Y. Morizawa, A. Yasuda, M. Otani, and Y. Mizushima. 1992. Lecithinization of superoxide dismutase potentiates its protective effect against Forssman antiserum-induced elevation in guinea pig airway resistance. J. Pharmacol. Exp. Ther. 262:1214-1219.
14. Buisson, A., I. Margaill, J. Callebert, M. Plotkine, and R.G. Boul. 1993. Mechanisms involved in the neuroprotective activity of a nitric oxide synthetase inhibitor during focal cerebral ischemia. J. Neurochem. 61:690-699.
15. Miyajima, T., and Y. Kotake. 1995. Spin trapping agent, phenyl N-tertbutyl nitrone, inhibits induction of nitric oxide synthetase in endotoxin-induced shock in mice. Biochem. Biophys. Res. Commun. 215:114-121.
16. Kashima, N., C. Nishi-Takaoka, T. Fujita, S. Taki, G. Yamada, J. Hamuro, and T. Taniguchi. 1985. Unique structure of murine interleukin-2 as deduced from cloned cDNAs. Nature (Lond.). 313:402-404.
17. Van-Snick, J., S. Cayphas, J.P. Szikora, J.C. Renauld, E. Van-Roost, T. Boon, and R.J. Simpson. 1988. cDNA cloning of murine interleukin-HP1: homology with human interleukin 6. Eur. J. Immunol. 18:193-197.
18. Pennica, D., J.S. Hayflick, T.S. Bringman, M.A. Palladino, and D.V. Goeddel. 1985. Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor. Proc. Natl. Acad. Sci. USA. 82:6060-6064.
19. Gray, P.W., and D.V. Goeddel. 1983. Cloning and expression of murine immune interferon cDNA. Proc. Natl. Acad. Sci. USA. 82:5842-5846.
20. Alonson, S., A. Minty, Y. Bourlet, and M. Buckingham. 1986. Comparison of three actin-coding sequences in the mouse; evolutionary relationships between the actin genes of warm-blooded vertebrates. J. Mol. Evol. 23:1-22.
21. Lyons, C.R., G.J. Orloff, and J.M. Cunningham. 1992. Molecular cloning and functional expression of an inducible nitric oxide synthetase from a murine macrophage cell line. J. Biol. Chem. 267:6370-6374.
22. Haining, J.L., and J.S. Legan. 1967. Fluorometric assay for xanthine oxidase. Anal. Chem. 21:337-343.
23. Guarner, C., G. Soriano, A. Thomas, O. Bulbena, M.T. Novella, J. Balanzo, F. Vilardell, M. Mourelle, and S. Moncada. 1993. Increased serum nitrite and nitrate levels in patients with cirrhosis: Relationship to toxemia. Hepatology. 18:1139-1143.
24. Fukuyama, N., K. Ichimori, Z. Su, H. Ishida, and H. Nakazawa. 1996. Peroxynitrite formation from activated human leukocytes. Biochem. Biophys. Res. Commun. 224:414-419.
25. Gow, A.J., D. Duran, S. Malcolm, and H. Ischiropoulos. 1996. Effect of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation. FEBS Lett. 385:63-66.
26. Kaur, H., and B. Halliwell. 1994. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett. 350:9-12.
27. Nathan, C.F., H.W. Murray, M.E. Wiebe, and B.Y. Rubin. 1983. Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158:670-689.
28. Nathan, C.F., C.R. Horowitz, J. de la Harpe, S. Vadhan-Raj, S.A. Sherwin, H.F. Oettgen, and S.E. Krown. 1985. Administration of recombinant interferon-γ to cancer patients enhances monocyte secretion of hydrogen peroxide. Proc. Natl. Acad. Sci. USA. 82:8686-8690.
29. Berton, G., L. Zemi, M. A. Cassatella, and F. Rossi. 1986. Gamma interferon is able to enhance the oxidative metabolism of human neutrophils. Biochem. Biophys. Res. Commun. 138:1276-1282.
30. Badger, A.M. 1986. Enhanced superoxide production by rat alveolar macrophage stimulated in vitro with biological response modifiers. J. Leukocyte Biol. 40:725-736.
31. Deng, W., B. Thiel, C.S. Tannenbaum, T.A. Hamilton, and D.J. Stuer. 1993. Synergistic cooperation between T cell lymphokines for induction of the nitric oxide synthetase gene in murine peritoneal macrophages. J. Immunol. 151:322-329.
32. Cox, G.W., G. Mellio, U. Chattopadhyay, D. Mullet, R.H. Fertel, and L. Varesio. 1992. Tumor necrosis factor-a - dependent production of reactive nitrogen intermediates mediates IFN-γ-plus IL-2 - induced murine macrophage tumoricidal activity. J. Immunol. 149:3290-3296.
33. Green, S.J., R.M. Crawford, J.T. Hockmeyer, M.S. Meltzer, and C.A. Nacy. 1990. Leishmania major amastigotes initiate the L-arginine - dependent killing mechanism in IFN-γ - stimulated macrophages by induction of tumor necrosis factor-α. J. Immunol. 145:4290-4297.
34. Mulligan, M.S., J.M. Hevel, M.A. Marietta, and P.A. Ward. 1991. Tissue injury caused by deposition of immune complex is L-arginine dependent. Proc. Natl. Acad. Sci. USA. 88:6338-6342.
35. McCartney-Francis, N., J.B. Allen, D.E. Mizel, J.E. Albina, Q.-W. Xie, C.F. Nathan, and S.M. Wahl. 1993. Suppression of arthritis by an inhibitor of nitric oxide synthetase. J. Exp. Med. 178:749-754.
36. Wink, D.A., M.B. Grisham, J.B. Mitchell, and P.C. Ford. 1996. Direct and indirect effects of nitric oxide in chemical reactions relevant to biology. In Methods in Enzymology. Vol. 268. Nitric oxide. Part A. Sources and detection of NO; NO synthetase. L. Parker, editor. Academic Press, Inc., San Diego, CA. 12-31.
37. Ischiropoulos, H., L. Zhu, and J.S. Beckman. 1992. Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 198:431-437.
38. Xia, Y., V.L. Dawson, T.M. Dawson, S.H. Snyder, and J.L. Zweier. 1996. Nitric oxide synthetase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc. Natl. Acad. Sci. USA. 93:6770-6774.
39. Akaike, T., Y. Noguchi, S. Ijiri, K. Setoguchi, M. Suga, Y.M. Zheng, B. Dietzschold, and H. Maeda. 1996. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc. Natl. Acad. Sci. USA. 93:2448-2453.
40. Crow, J.P., and J.S. Beckman. 1995. The role of peroxynitrite in nitric oxide-mediated toxicity. In The Role of Nitric Oxide in Physiology and Pathophysiology, K. Koprowski and H. Maeda, editors. Springer-Verlag, Berlin. 57-74.
41. Anderson. J.A., A.B. Lentsch, D.J. Hadjiminas, F.N. Miller, A.W. Martin, K. Nakagawa, and M.J. Edwards. 1996. The role of cytokines, adhesion molecules, and chemokines in interleukin-2-induced lymphocytic infiltration in C57BL/6 mice. J. Clin. Invest. 97:1952-1959.
42. Schall, T.J., K. Bacon, K.J. Toy, and D.V. Goeddel. 1990. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature (Lond.). 347:669-671.
43. Monti, G., A. Magnan, M. Fattal, B. Rain, M. Humbert, J.-L. Mege, M. Noirclerc, P. Dartevelle, J. Cerrina, G. Simonneau, et al. 1996. Intrapulmonary production of RANTES during rejection and CMV pneumonitis after lung transplantation. Transplantation. 61:1757-1762.
44. Szabo, C. 1995. Alterations in nitric oxide production in various forms of circulatory shock. New Horizons. 3:2-32.
45. Yamashita, T., I. Kuwahira, S. Harasawa, T. Miwa, T. Oka, H. Mori, and H. Nakazawa. 1996. Role of EDRF/NO in regional vascular resistance in pharmacologically denervated rats. Pathophysiology. 3:149-156.